U.S. flag An official website of the United States government
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: November 10-16, 2019
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: November 10-16, 2019

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Brett P. Giroir, M.D, Acting Commissioner of Food and Drugs

Event Date: 11/13/2019
Location: Silver Spring, MD
Subject: Cancer Research (Telephone Call)
FDA Participant/Group: KEAGAN LENIHAN;
Non FDA Participant/Group: Harry Reid (Former Senator);

Official Name: Amy Abernethy, M.D., Ph.D, Principal Deputy Commissioner

Event Date: 11/13/2019
Location: Los Angeles, CA
Subject: a16z Summit 2019; A Fireside Chat With Amy Abernethy - Innovation in Medicine, Healthcare, and Policy
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees from industry, academia, and the media

Official Name: Anna Abram, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

No Significant Event

Official Name: Lowell Schiller, Principal Associate Commissioner for Policy

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

Event Date: 11/11/2019
Location: New Delhi, India
Subject: India Pharmaceutical and Good Manufacturing Processes (GMP) Issues
FDA Participant/Group: N/A
Non FDA Participant/Group: 4th Indian Pharmaceutical Alliance Advanced GMP Workshop attendees

Event Date: 11/13/2019
Location: New Delhi, India
Subject: Indian Food and Medical Product Exports
FDA Participant/Group: N/A
Non FDA Participant/Group: Gujarat Food and Drug Control Administration representatives

Event Date: 11/14/2019
Location: New Delhi, India
Subject: India Pharmaceutical Manufacturing and Quality
FDA Participant/Group: N/A
Non FDA Participant/Group: 3rd Annual Regulatory Forum and Bilateral Meeting with Government of India Central Drug Standard Control Organization (CDSCO) representatives

Official Name: Melinda Plaisier, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs

No Significant Event

Official Name: Laura Caliguiri, Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

No Significant Event

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

Event Date: 11/15/2019
Location: College Park, MD
Subject: Meeting with American Cheese Society (ACS)- Various Food Issues
FDA Participant/Group: WILLIAM CORRELL; JENNIFER DOOREN; JOHN SHEEHAN; PAUL SOUTH; MICKEY PARISH;
Non FDA Participant/Group: N/A

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Stacy Cline Amin, Chief Counsel

No Significant Event